What is Arboris?
Arboris, LLC operates as the premier global producer of naturally-occurring plant sterols, specializing in cholesterol-reducing compounds extracted from pine trees. By utilizing a renewable, non-GMO feedstock, the company provides a 99% pure mixture of phytosterols that are integrated into a wide array of consumer goods, including spreads, juices, dairy products, and baked goods. Their market position is defined by a commitment to rigorous quality standards and a sustainable supply chain that appeals to health-conscious consumers and enterprise-level food producers alike. The company's core competency lies in its ability to scale the production of these essential compounds while maintaining the purity levels required for high-end food fortification.
How much funding has Arboris raised?
Arboris has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Arboris
PPP
Public-Private Partnership
What's next for Arboris?
With the recent influx of capital, Arboris is well-positioned to expand its manufacturing capacity and further optimize its supply chain efficiency. The strategic focus will likely center on deepening its penetration into the functional food and beverage market, where the demand for heart-healthy, plant-derived ingredients continues to accelerate. By reinvesting in its core extraction technologies, the company aims to maintain its competitive edge against synthetic alternatives, ensuring that its pine-derived sterols remain the gold standard for purity and efficacy. Future growth will likely involve scaling production to support global distribution partnerships, solidifying its status as an essential partner for multinational food conglomerates seeking to enhance the nutritional profile of their product portfolios.
See full Arboris company page
